NTRA - ナテラ (Natera Inc.)

NTRAのニュース

   U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent  2020/12/18 14:03:00 Benzinga
SAN CARLOS, Calif. , Dec. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA ), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office granted Natera a significant win when it denied a patentability challenge from a multi-national sequencing company against Natera's U.S. Patent No. 8,682,592 ('592 Patent) upholding all claims. Natera's '592 Patent claims early and significant innovations directed to generating genetic data from limited quantities of DNA, including cfDNA. Natera has shown the techniques to be useful in a variety of contexts such as non-invasive prenatal testing, ctDNA molecular residual disease testing in oncology, and donor-derived cfDNA assessment in organ transplant recipients. In upholding the … Full story available on Benzinga.com
   New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial  2020/12/09 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 9, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that new data will be presented on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, in an oral…
   Natera to Present New Immunotherapy Monitoring Data at SABCS 2020  2020/12/08 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 8, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed circulating tumor DNA (ctDNA) assay, Signatera,™ at the 2020 virtual San…
   Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies  2020/12/03 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health plan in the United States has extended coverage of non-invasive prenatal tests (NIPT) to all…
   Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies  2020/12/01 15:32:00 PR Newswire
SAN CARLOS, Calif., Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the largest health plan in the United States has extended coverage of NIPT to all pregnancies. The expanded coverage comes only a few…
   New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial  2020/12/09 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 9, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that new data will be presented on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, in an oral…
   Natera to Present New Immunotherapy Monitoring Data at SABCS 2020  2020/12/08 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 8, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed circulating tumor DNA (ctDNA) assay, Signatera,™ at the 2020 virtual San…
   Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies  2020/12/03 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health plan in the United States has extended coverage of non-invasive prenatal tests (NIPT) to all…
   Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies  2020/12/01 15:32:00 PR Newswire
SAN CARLOS, Calif., Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the largest health plan in the United States has extended coverage of NIPT to all pregnancies. The expanded coverage comes only a few…
   Natera Appoints Dr. Monica Bertagnolli to its Board of Directors  2020/11/19 14:03:00 PR Newswire
SAN CARLOS, Calif., Nov. 19, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors. "We are delighted to welcome Dr. Bertagnolli to our board at this…
   New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial  2020/12/09 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 9, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that new data will be presented on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, in an oral…
   Natera to Present New Immunotherapy Monitoring Data at SABCS 2020  2020/12/08 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 8, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed circulating tumor DNA (ctDNA) assay, Signatera,™ at the 2020 virtual San…
   Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies  2020/12/03 14:03:00 PR Newswire
SAN CARLOS, Calif., Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health plan in the United States has extended coverage of non-invasive prenatal tests (NIPT) to all…
   Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies  2020/12/01 15:32:00 PR Newswire
SAN CARLOS, Calif., Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the largest health plan in the United States has extended coverage of NIPT to all pregnancies. The expanded coverage comes only a few…
   Natera Appoints Dr. Monica Bertagnolli to its Board of Directors  2020/11/19 14:03:00 PR Newswire
SAN CARLOS, Calif., Nov. 19, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors. "We are delighted to welcome Dr. Bertagnolli to our board at this…

calendar